EMD photo

Eve Damiano

Clinical Operations and Regulatory Compliance

Eve Damiano, MS, RAC, has over 30 years of professional experience in the Biotechnology Sector, specializing in regulatory affairs and GxP compliance.  Ms. Damiano has garnered depth of expertise from discovery through post-marketing activities, including various therapeutic areas.  She has served in senior management positions at multiple companies, and in a broad range of therapeutic areas.  Ms. Damiano has prepared numerous applications to support investigation and marketing of FDA regulated products. She holds an accomplished track record in the definition and execution of development/regulatory strategies, including innovative solutions and effective management of projects and resources to meet company objectives.  Ms. Damiano earned her BS degree from California University of Pennsylvania and MS degree from The Drexel College of Medicine, and has been a Regulatory Affairs Certified (RAC) professional since 2006.

Rohinton LinkedIn

Rohinton Tarapore, Ph.D.

Associate Director, Clinical Research

Rohinton manages the non-clinical studies and clinical trials, and drafts reports and communication material targeted for the FDA.  Dr. Tarapore received his PhD. from the University of Wisconsin – Madison and did his postdoctoral training at the University of Pennsylvania Medical School. While at Penn, he was co-chair of the Biomedical Postdoctoral Council, conceptualized the idea of hosting vendor shows & raised $65,000 for postdoctoral-related activities, and drafted several policies for enhancing the post-doctoral training at the institution. Dr. Tarapore has authored several research publications in cancer signaling, small molecules, inflammation, diabetes and toxicology and has a deep knowledge on signaling pathways that are de-regulated in oncology. Dr. Tarapore joined Oncoceutics at the beginning of 2015.


Varun Prabhu, Ph.D.

Associate Director, Research and Development

Varun is responsible for supporting preclinical activities, as well as pursuing opportunities for grants and research collaborations. He has worked collaboratively with Oncoceutics since 2012, as a researcher in the lab of scientific founder Dr. Wafik El-Deiry, on the mechanism of action, biomarkers and combinatorial efficacy of ONC201. Dr. Prabhu was the first to demonstrate the anti-cancer stem cell efficacy of ONC201. He has co-authored several peer-reviewed publications exploring cancer therapeutics targeting apoptosis pathways, tumor suppressor genes and stem cell self-renewal. He completed his B.S. in Pharmaceutical Sciences from the Institute of Chemical Technology in India, received a M.S. in Biotechnology from the University at Buffalo, SUNY and earned a Ph.D. in Molecular Medicine from Pennsylvania State University. He has previously held research positions at the Roswell Park Cancer Institute, the Fox Chase Cancer Center and OncoMed Pharmaceuticals. Dr. Prabhu has received several awards including the Penn State Alumni Association Dissertation Award and an Innovation Award from MedImmune.

Krystal Merdinger

Senior Clinical Data Manager

Krystal manages the clinical trial data within various Electronic Data Capturing platforms, provides end-user support and training for the REDCap Cloud EDC System, creates reports for leadership, and manages regulatory documents for new and ongoing clinical trials. She joins Oncoceutics having most recently been a Clinical Research Systems Manager at Fox Chase Cancer Center in the Office of Clinical Research overseeing the clinical data for over 1300 clinical trials. She completed her B.S. in Public Health from Temple University minoring in Epidemiology and Biostatistics and is pursuing a M.S. in Health Informatics from Temple University. Krystal has worked in several clinical research settings such as behavioral and emergency medicine with Fox Chase Cancer Center and The Hospital at the University of Pennsylvania.